Patent 7709607 was granted and assigned to Xencor on May, 2010 by the United States Patent and Trademark Office.
An adiponectin variant with one or more amino acid modifications relative to a corresponding parent adiponectin, wherein the solubility of the variant is improved by at least 3-fold relative to residues 110-244 of human adiponectin.